Olena Barbash

5.4k total citations
34 papers, 2.5k citations indexed

About

Olena Barbash is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Olena Barbash has authored 34 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Hematology. Recurrent topics in Olena Barbash's work include Protein Degradation and Inhibitors (12 papers), Ubiquitin and proteasome pathways (12 papers) and Cancer-related gene regulation (11 papers). Olena Barbash is often cited by papers focused on Protein Degradation and Inhibitors (12 papers), Ubiquitin and proteasome pathways (12 papers) and Cancer-related gene regulation (11 papers). Olena Barbash collaborates with scholars based in United States, United Kingdom and Canada. Olena Barbash's co-authors include Caretha L. Creasy, Helai P. Mohammad, J. Alan Diehl, Anil K. Rustgi, Peter J. Tummino, Ryan G. Kruger, Douglas I. Lin, Steven F. Abcouwer, David L. Vander Jagt and Andres J. Klein–Szanto and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Olena Barbash

34 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Olena Barbash United States	24	2.2k	616	296	288	211	34	2.5k
Jorge A. Almenara United States	22	1.7k 0.8×	454 0.7×	235 0.8×	243 0.8×	286 1.4×	36	2.1k
Jung-Sik Kim United States	26	1.5k 0.7×	596 1.0×	406 1.4×	232 0.8×	76 0.4×	45	2.2k
Kuntian Luo China	22	2.1k 1.0×	848 1.4×	327 1.1×	276 1.0×	80 0.4×	40	2.4k
Hans-Guido Wendel United States	14	2.1k 1.0×	542 0.9×	380 1.3×	106 0.4×	193 0.9×	20	2.5k
Xiaofen Ye United States	17	1.5k 0.7×	446 0.7×	167 0.6×	106 0.4×	206 1.0×	33	2.1k
Weili Ma Taiwan	16	1.3k 0.6×	986 1.6×	348 1.2×	149 0.5×	109 0.5×	59	2.0k
Meike Vogler Germany	26	2.1k 1.0×	769 1.2×	362 1.2×	133 0.5×	290 1.4×	59	2.9k
Emily Chu United States	7	1.3k 0.6×	627 1.0×	191 0.6×	225 0.8×	68 0.3×	14	1.7k
Ronald B. Gartenhaus United States	33	1.7k 0.8×	449 0.7×	436 1.5×	135 0.5×	174 0.8×	75	2.5k
David K. Strom United States	15	1.5k 0.7×	1.2k 1.9×	200 0.7×	391 1.4×	236 1.1×	17	2.0k

Countries citing papers authored by Olena Barbash

Since Specialization

Citations

This map shows the geographic impact of Olena Barbash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olena Barbash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olena Barbash more than expected).

Fields of papers citing papers by Olena Barbash

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olena Barbash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olena Barbash. The network helps show where Olena Barbash may publish in the future.

Co-authorship network of co-authors of Olena Barbash

This figure shows the co-authorship network connecting the top 25 collaborators of Olena Barbash. A scholar is included among the top collaborators of Olena Barbash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olena Barbash. Olena Barbash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Hailei, Anna Rutkowska, Antonio González-Martı́n, et al.. (2024). Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical Trials. Cancer Research Communications. 5(1). 178–186. 1 indexed citations

Cescon, David W., John Hilton, Serafín Morales, et al.. (2023). A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor–positive/HER2-negative Advanced or Metastatic Breast Cancer. Clinical Cancer Research. 30(2). 334–343. 10 indexed citations

Fedoriw, Andrew, Leilei Shi, Shane W. O’Brien, et al.. (2022). Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses. Cancer Immunology Research. 10(4). 420–436. 26 indexed citations

Zappacosta, Francesca, Craig D. Wagner, Anthony Della Pietra, et al.. (2021). A Chemical Acetylation-Based Mass Spectrometry Platform for Histone Methylation Profiling. Molecular & Cellular Proteomics. 20. 100067–100067. 8 indexed citations

Kellner, Wendy A., Christine Thompson, Melissa B. Pappalardi, et al.. (2018). Activation of the p53-MDM4 regulatory axis defines the anti-tumour response to PRMT5 inhibition through its role in regulating cellular splicing. Scientific Reports. 8(1). 9711–9711. 121 indexed citations

Wyce, Anastasia, Shawn W. Foley, Satyajit Rajapurkar, et al.. (2018). MEK inhibitors overcome resistance to BET inhibition across a number of solid and hematologic cancers. Oncogenesis. 7(4). 35–35. 23 indexed citations

Chiang, Kelly, Agnieszka Zielińska, Abeer M. Shaaban, et al.. (2017). PRMT5 Is a Critical Regulator of Breast Cancer Stem Cell Function via Histone Methylation and FOXP1 Expression. Cell Reports. 21(12). 3498–3513. 137 indexed citations

O’Dwyer, Peter J., Sarina A. Piha‐Paul, Christopher A. French, et al.. (2016). Abstract CT014: GSK525762, a selective bromodomain (BRD) and extra terminal protein (BET) inhibitor: results from part 1 of a phase I/II open-label single-agent study in patients with NUT midline carcinoma (NMC) and other cancers. Cancer Research. 76(14_Supplement). CT014–CT014. 26 indexed citations

Mazur, Paweł K., Nicolas Reynoird, Purvesh Khatri, et al.. (2014). SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer. Nature. 510(7504). 283–287. 285 indexed citations

10.

Wyce, Anastasia, Gopinath Ganji, Kimberly N. Smitheman, et al.. (2013). BET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor Models. PLoS ONE. 8(8). e72967–e72967. 151 indexed citations

11.

Aller, Glenn S. Van, Nicolas Reynoird, Olena Barbash, et al.. (2012). Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation. Epigenetics. 7(4). 340–343. 140 indexed citations

12.

Barbash, Olena, et al.. (2011). Phosphorylation-dependent regulation of SCFFbx4 dimerization and activity involves a novel component, 14-3-3ɛ. Oncogene. 30(17). 1995–2002. 26 indexed citations

13.

Barbash, Olena, et al.. (2009). Lysine 269 is essential for cyclin D1 ubiquitylation by the SCFFbx4/αB-crystallin ligase and subsequent proteasome-dependent degradation. Oncogene. 28(49). 4317–4325. 28 indexed citations

14.

Barbash, Olena & J. Alan Diehl. (2008). SCFFbx4/αB-crystallin E3 ligase: When one is not enough. Cell Cycle. 7(19). 2983–2986. 35 indexed citations

15.

Barbash, Olena, Douglas I. Lin, Xiangmei Chen, et al.. (2008). Mutations in Fbx4 Inhibit Dimerization of the SCFFbx4 Ligase and Contribute to Cyclin D1 Overexpression in Human Cancer. Cancer Cell. 14(1). 68–78. 118 indexed citations

16.

Pontano, Laura, Priya Aggarwal, Olena Barbash, et al.. (2008). Genotoxic Stress-Induced Cyclin D1 Phosphorylation and Proteolysis Are Required for Genomic Stability. Molecular and Cellular Biology. 28(23). 7245–7258. 63 indexed citations

17.

Lin, Douglas I., Olena Barbash, Suresh Kumar, et al.. (2006). Phosphorylation-Dependent Ubiquitination of Cyclin D1 by the SCFFBX4-αB Crystallin Complex. Molecular Cell. 24(3). 355–366. 299 indexed citations

18.

Benzeno, Sharon, Fengmin Lu, Mian Guo, et al.. (2006). Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1. Oncogene. 25(47). 6291–6303. 110 indexed citations

19.

Roybal, C. Nathaniel, Lucy A. Hunsaker, Olena Barbash, David L. Vander Jagt, & Steven F. Abcouwer. (2005). The Oxidative Stressor Arsenite Activates Vascular Endothelial Growth Factor mRNA Transcription by an ATF4-dependent Mechanism. Journal of Biological Chemistry. 280(21). 20331–20339. 112 indexed citations

20.

Bobrovnikova-Marjon, Ekaterina, et al.. (2004). Expression of Angiogenic Factors Vascular Endothelial Growth Factor and Interleukin-8/CXCL8 Is Highly Responsive to Ambient Glutamine Availability. Cancer Research. 64(14). 4858–4869. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact